Posted by Michael Wonder on 26 Aug 2021
Innovative Health Sciences receives FDA clearance for Insignis subcutaneous needle sets
26 August 2021 - Innovative Health Sciences announced today that it has received FDA clearance for its Insignis subcutaneous needle sets.
The state of the art Insignis subcutaneous needle sets deliver an improved patient experience with reduced pain at a lower cost for the subcutaneous infusion of medications in the home, hospital, ambulatory, or clinic setting.
